Trevi Therapeutics (TRVI) Tax Provisions (2018 - 2026)
Trevi Therapeutics' (TRVI) quarterly Tax Provisions came in at -$20000.0 in Q1 2026, down 81.82% year-on-year from -$110000.0 in Q1 2025, and up 4.76% quarter-over-quarter from -$21000.0 in Q4 2025.
Trevi Therapeutics (TRVI) Tax Provisions (2018 - 2026) Analysis & Trends
Trevi Therapeutics' Tax Provisions history runs 9 years deep, the most recent figure standing at -$20000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 81.82% year-over-year to -$20000.0 in Q1 2026; TTM through Mar 2026 was -$77000.0, a 10.47% increase from a year earlier, with the FY2025 full-year figure at -$69000.0, up 15.85% from the prior year.
- Tax Provisions advanced to -$20000.0 in Q1 2026 per TRVI's latest filing, from -$21000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $18000.0 in Q4 2023 and bottomed at -$36000.0 in Q4 2024.
- The 5-year median for Tax Provisions is -$13000.0 (2023), against an average of -$14058.8.
- Biggest YoY gain for Tax Provisions was 190.0% in 2023; the steepest drop was 650.0% in 2023.
- Year by year, Tax Provisions stood at -$20000.0 in 2022, then soared by 190.0% to $18000.0 in 2023, then sank by 300.0% to -$36000.0 in 2024, then soared by 41.67% to -$21000.0 in 2025, then gained by 4.76% to -$20000.0 in 2026.
- Per Business Quant, the three latest TRVI Tax Provisions figures stand at -$20000.0 (Q1 2026), -$21000.0 (Q4 2025), and -$15000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Trevi Therapeutics | 2.54 Bn | 2.54 Bn | - | -20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | -36,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -30,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -20,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -4,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | -2,000.00 |